Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice?

Pharmacology and Therapeutics

Volumn 115, Issue 1, 2007, Pages 37-55

  Penson, Peter E ^a   Ford, William R ^a   Broadley, Kenneth J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adrenaline; Adrenoceptor agonists; Advanced cardiac life support; Cardiopulmonary resuscitation; Epinephrine; Vasopressors

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CATECHOLAMINE DERIVATIVE; CORBADRINE; DOXAZOSIN; HYPERTENSIVE FACTOR; ISOPRENALINE; METHOXAMINE; METOPROLOL; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PRAZOSIN; VASOPRESSIN;

BRAIN CIRCULATION; CELL CULTURE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPRESSION; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DESENSITIZATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; HEART ARREST; HEART MUSCLE ISCHEMIA; HISTORY OF MEDICINE; HUMAN; HYPOKALEMIA; ISCHEMIA; LUNG VENTILATION; MAST CELL; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; RESUSCITATION; REVIEW; THORAX; THROMBOCYTE AGGREGATION; VASOCONSTRICTION;

ANIMALS; CARDIOPULMONARY RESUSCITATION; EPINEPHRINE; HEART ARREST; HUMANS; MYOCARDIAL ISCHEMIA; VASOCONSTRICTOR AGENTS;

EID: 34250841703     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.03.003     Document Type: Review

References (151)

1. Abbs E.T., Broadley K.J., and Roberts D.J. Inhibition of catechol-o-methyl transferase by some acid degradation products of adrenaline and noradrenaline. Biochem Pharmacol 16 (1967) 279-282
2. Ahlquist R.P. A study of adrenotropic receptors. Am J Physiol Heart Circ Physiol 153 (1948) 586-600
3. American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: Part 7.2. Management of cardiac arrest. Circ J 112 (2005) IV-58-66
4. Andreka P., and Frenneaux M.P. Haemodynamics of cardiac arrest and resuscitation. Curr Opin Crit Care 12 3 (2006) 198-203
5. Awan M.M., Taunyane C., Aitchison K.A., Yellon D.M., and Opie L.H. Normothermic transfer times up to 3 min will not precondition the isolated rat heart. J Mol Cell Cardiol 31 3 (1999) 503-511
6. Babbs C.F., Berg R.A., Kette F., Kloeck W.G., Lindner K.H., Lurie K.G., et al. Use of pressors in the treatment of cardiac arrest. Ann Emerg Med 37 4 Suppl (2001) S152-S162
7. Barton C., and Callaham M. High-dose epinephrine improves the return of spontaneous circulation rates in human victims of cardiac-arrest. Ann Emerg Med 20 7 (1991) 722-725
8. Beers M.H., and Berkow R. Electric injury. In: Beers M.H., and Berkow R. (Eds). The merck manual of diagnosis and therapy (1999), Merck Research Laboratories, Whitehouse Station, NJ 2441-2443
9. Beers M.H., and Berkow R. Water, electrolyte, mineral, and acid-base metabolism. In: Beers M.H., and Berkow R. (Eds). The merck manual of diagnosis and therapy (1999), Merck Research Laboratories, Whitehouse Station, NJ 120-164
10. Beers M.H., and Berkow R. Cardiac and respiratory arrest and cardiopulmonary resuscitation. In: Beers M.H., and Berkow R. (Eds). The merck manual of diagnosis and therapy (1999), Merck Research Laboratories, Whitehouse Station, NJ 1740-1753
11. Behonick G.S., Novak M.J., Nealley E.W., and Baskin S.I. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J Appl Toxicol 21 Suppl 1 (2001) S15-S22
12. Behringer W., Kittler H., Sterz F., Domanovits H., Schoerkhuber W., Holzer M., et al. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Ann Intern Med 129 6 (1998) 450-456
13. Bindoli A., Rigobello M.P., and Deeble D.J. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 13 4 (1992) 391-405
14. Blancke F., Claeys M.J., Jorens P., Vermeiren G., Bosmans J., Wuyts F.L., et al. Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediat Inflamm 6 (2005) 385-389
15. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword?. J Clin Invest 76 5 (1985) 1713-1719
16. Brembilla-Perrot W., Miljoen H., Houriez P., Beurrier D., Nippert M., Vancon A.C., et al. Causes and prognosis of cardiac arrest in a population admitted to a general hospital; a diagnostic and therapeutic problem. Resuscitation 58 3 (2003) 319-327
17. Broadley K.J., and Penson P.E. The roles of α- and β-adrenoceptor stimulation in myocardial ischaemia. Auton Autacoid Pharmacol 24 4 (2004) 87-93
18. Broadley K.J., Williamson K.L., and Roach A.G. In vivo demonstration of α-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial α-adrenoceptors. J Autonom Pharmacol 19 (1999) 55-63
19. Brown C.G., and Werman H.A. Adrenergic agonists during cardiopulmonary resuscitation. Resuscitation 19 1 (1990) 1-16
20. Brown C.G., Taylor R.B., Werman H.A., Luu T., Spittler G., and Hamlin R.L. Effect of Standard Doses of Epinephrine on Myocardial Oxygen Delivery and Utilization during Cardiopulmonary Resuscitation. Crit Care Med 16 5 (1988) 536-539
21. Brown C.G., Martin D.R., Pepe P.E., Stueven H., Cummins R.O., Gonzalez E., et al. A comparison of standard-dose and high-dose epinephrine in cardiac-arrest outside the hospital. N Engl J Med 327 15 (1992) 1051-1055
22. Callaham M., Barton C.W., and Kayser S. Potential complications of high-dose epinephrine therapy in patients resuscitated from cardiac-arrest. JAMA- J Am Med Assoc 265 9 (1991) 1117-1122
23. Callaham M., Madsen C.D., Barton C.W., Saunders C.E., and Pointer J. A randomized clinical-trial of high-dose epinephrine and norepinephrine vs. standard-dose epinephrine in prehospital cardiac-arrest. JAMA-J Am Med Assoc 268 19 (1992) 2667-2672
24. Cameron H.A., and Ardlie N.G. The facilitating effects of adrenaline on platelet aggregation. Prostaglandins Leukot Med 9 1 (1982) 117-128
25. Camm A.J. Cardiovascular disease. In: Kumar P., and Clark M. (Eds). Clinical medicine (2002), W.B. Saunders, London 701-832
26. Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190 3 (2000) 255-266
27. Cartwright M.S., and Reynolds P.S. Intracerebral hemorrhage associated with over-the-counter inhaled epinephrine. Cerebrovasc Dis 19 6 (2005) 415-416
28. 2-adrenergic receptors in the coronary microcirculation. Circulation 84 5 (1991) 2108-2022
29. Choudhary H.R., Jain R., and Arora H. Adrenaline precipitated intracerebral hemorrhage. J Assoc Phys India 47 5 (1999) 562
30. Cooper S., Janghorbani M., and Cooper G. A decade of in-hospital resuscitation: Outcomes and prediction of survival?. Resuscitation 68 2 (2006) 231-237
31. Crile G., and Dolley D. An experimental research into the resuscitation of dogs killed by anaesthetics and asphyxia. J Exp Med 8 (1906) 713-725
32. Dahlgren N., Rosen I., Sakabe T., and Siesjo B.K. Cerebral functional, metabolic and circulatory effects of intravenous-infusion of adrenaline in the rat. Brain Res 184 1 (1980) 143-152
33. DeBehnke D. The effects of graded doses of endothelin-1 on coronary perfusion pressure and vital organ blood flow during cardiac arrest. Acad Emerg Med 7 3 (2000) 211-221
34. DeBehnke D.J., and Benson L. Effects of endothelin-1 on resuscitation rate during cardiac arrest. Resuscitation 47 2 (2000) 185-189
35. DeBehnke D.J., Spreng D., Wickman L.L., and Crowe D.T. The effects of endothelin-1 on coronary perfusion pressure during cardiopulmonary resuscitation in a canine model. Acad Emerg Med 3 2 (1996) 137-141
36. Dhalla N.S., Yates J.C., Lee S.L., and Singh A. Functional and subcellular changes in the isolated rat heart perfused with oxidised isoproterenol. J Mol Cell Cardiol 10 (1978) 31-41
37. Ditchey R.V., and Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen-supply and demand during closed-chest resuscitation in dogs. Circulation 78 2 (1988) 382-389
38. 2-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. Gen Pharmacol 34 2 (2000) 101-106
39. Engdahl J., Bang A., Karlson B.W., Lindqvist J., and Herlitz J. Characteristics and outcome among patients suffering from out of hospital cardiac arrest of non-cardiac aetiology. Resuscitation 57 1 (2003) 33-41
40. Fang X.S., Tang W.C., Sun S.J., Huang L., Chang Y.T., Huang Z.T., et al. Cardiopulmonary resuscitation in a rat model of chronic myocardial ischemia. J Appl Physiol 101 4 (2006) 1091-1096
41. Feuerstein G., Yue T.-L., Cheng H.-Y., Hieble J.P., Arch J.R.S., Ruffolo Jr. R.R., et al. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. Eur J Pharmacol 351 3 (1998) 341-350
42. Fischer M., Fischer N.J., and Schuttler J. One-year survival after out-of-hospital cardiac arrest in Bonn city: Outcome report according to the "Utstein style". Resuscitation 33 3 (1997) 233-243
43. Foley P.J., Tacker W.A., Wortsman J., Frank S., and Cryer P.E. Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol 253 3 Pt 1 (1987) E283-E289
44. Fujita M., and Tambara K. Recent insights into human coronary collateral development. Heart 90 3 (2004) 246-250
45. Ganong W.F. Review of medical physiology (2001), Lange Medical, New York
46. Gao F., Chen J., Lopez B.L., Christopher T.A., Gu J., Lysko P., et al. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol 406 1 (2000) 109-116
47. Gonzalez E.R., Ornato J.P., Garnett A.R., Levine R.L., Young D.S., and Racht E.M. Dose-dependent vasopressor response to epinephrine during CPR in human beings. Ann Emerg Med 18 9 (1989) 920-926
48. Gottlieb R. Ueber die Wirkung der Nebennierenextracte auf herz und blutdruk. Naunyn-Schmiedeberg's Arch Pharmacol 38 (1896) 99-112
49. Green D.E., and Richter D. Adrenaline and adrenochrome. Biochem J 31 (1937) 596-616
50. Gregorini L., Marco J., Kozakova M., Palombo C., Anguissola G.B., Marco I., et al. α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 99 4 (1999) 482-490
51. 2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106 23 (2002) 2901-2907
52. Gross E.R., and Gross G.J. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70 2 (2006) 212-221
53. Grubb N.R., Elton R.A., and Fox K.A.A. In-hospital mortality after out-of-hospital cardiac-arrest. Lancet 346 8972 (1995) 417-421
54. Gueugniaud P.Y., Mols P., Goldstein P., Pham E., Dubien P.Y., Deweerdt C., et al. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. N Engl J Med 339 22 (1998) 1595-1601
55. Guimaraes S., and Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 53 2 (2001) 319-356
56. Guyette F.X., Guimond G.E., Hostler D., and Callaway C.W. Vasopressin administered with epinephrine is associated with a return of a pulse in out-of-hospital cardiac arrest. Resuscitation 63 3 (2004) 277-282
57. Hearse D.J. The elusive coypu: the importance of collateral flow and the search for an alternative to the dog. Cardiovasc Res 45 1 (2000) 215-219
58. Herlitz J., Ekstrom L., Wennerblom B., Axelsson A., Bang A., and Holmberg S. Adrenaline in out-of-hospital ventricular-fibrillation - does it make any difference. Resuscitation 29 3 (1995) 195-201
59. Hermreck A.S. The history of cardiopulmonary resuscitation. Am J Surg 156 6 (1988) 430-436
60. Hess E.P., Campbell R.L., and White R.D. Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin. Resuscitation 72 2 (2007) 200-206
61. Heyndrickx G.R., Millard R.W., and McRitchie R.J. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56 4 (1975) 978-985
62. Hieble J.P. Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. Pharm Acta Helv 74 (2000) 163-171
63. Hilwig R.W., Kern K.B., Berg R.A., Sanders A.B., Otto C.W., and Ewy G.A. Catecholamines in cardiac arrest: role of α-agonists, β-adrenergic blockers and high-dose epinephrine. Resuscitation 47 2 (2000) 203-208
64. Hoffman B.B. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman & Gilman's The pharmacological basis of therapeutics (2001), McGraw-Hill, London 215-268
65. Hoffman B.B., and Taylor P. Neurotransmission, the autonomic and somatic nervous systems. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (2001), McGraw-Hill, London 115-153
66. Holmberg M., Holmberg S., and Herlitz J. Low chance of survival among patients requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac arrest in Sweden. Resuscitation 54 1 (2002) 37-45
67. Hornchen U., Lussi C., and Schuttler J. Potential risks of high-dose epinephrine for resuscitation from ventricular fibrillation in a porcine model. J Cardiothorac Vasc Anesth 7 2 (1993) 184-187
68. 1- and β-actions of epinephrine during cardiopulmonary resuscitation. Crit Care Med 34 12 (2006) S483-S485
69. International Liaison Committee on Resuscitation. Part 4. Advanced life support. Resuscitation 67 2-3 (2005) 213-247
70. 2-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia. Cardiovasc Res 49 1 (2001) 218-225
71. Johansson J., Gedeborg R., and Rubertsson S. Vasopressin versus continuous adrenaline during experimental cardiopulmonary resuscitation. Resuscitation 62 1 (2004) 61-69
72. 2-Adrenergic receptor signalling in hypertension. Clin Sci 109 (2005) 431-437
73. Karch S.B. Coronary artery spasm induced by intravenous epinephrine overdose. Am J Emerg Med 7 5 (1989) 485-488
74. Kern K.B., Ewy G.A., Voorhees W.D., Babbs C.F., and Tacker W.A. Myocardial perfusion pressure: a predictor of 24-hour survival during prolonged cardiac arrest in dogs. Resuscitation 16 4 (1988) 241-250
75. Kern K.B., Elchisak M.A., Sanders A.B., Badylak S.F., Tacker W.A., and Ewy G.A. Plasma catecholamines and resuscitation from prolonged cardiac arrest. Crit Care Med 17 8 (1989) 786-791
76. Kilgore K.S., Tanhehco E.J., Naylor K.B., and Lucchesi B.R. Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion. J Pharmacol Exp Ther 290 3 (1999) 1041-1047
77. Klouche K., Weil M.H., Sun S., Tang W., and Zhao D.H. A comparison of α-methylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation. Resuscitation 57 1 (2003) 93-100
78. Kolarova J., Yi Z., Ayoub I.M., and Gazmuri R.J. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation. Chest 127 4 (2005) 1327-1334
79. Kuisma M., and Alaspaa A. Out-of-hospital cardiac arrests of non-cardiac origin - Epidemiology and outcome. Eur Heart J 18 7 (1997) 1122-1128
80. Kwon O., Chung S., Lee K., and Kim S. Spontaneous subarachnoid hemorrhage after intravenous epinephrine use for multiple bee stings. Am J Emerg Med 25 2 (2007) 249-250
81. LaBruno S., Naim K.L., Li J.K., Drzewiecki G., and Kedem J. β-Adrenergic stimulation of reperfused myocardium after 2-hour ischemia. J Cardiovasc Pharmacol 32 4 (1998) 535-542
82. 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation 84 4 (1991) 1608-1614
83. Lazzarino G., Raatikainen P., Nuutinen M., Nissinen J., Tavazzi B., Di Pierro D., et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation 90 1 (1994) 291-297
84. Lee S., Harris N.D., Robinson R.T., Yeoh L., Macdonald I.A., and Heller S.R. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest 33 2 (2003) 93-98
85. Levick J.R. An introduction to cardiovascular physiology (2003), Hodder Arnold, London
86. Lichtenstein S.V., El-Dalati H., Panos A., Rice T.W., and Salerno T.A. Systemic vascular effects of epinephrine administration in man. J Surg Res 42 2 (1987) 166
87. Lilja G.P., Long R.S., and Ruiz E. Augmentation of systolic blood pressure during external cardiac compression by use of the MAST suit. Ann Emerg Med 10 4 (1981) 182-184
88. Lindner K.H., Ahnefeld F.W., and Prengel A.W. Comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation. Acta Anaesthesiol Scand 35 3 (1991) 253-256
89. Lindner K.H., Ahnefeld F.W., and Bowdler I.M. Comparison of different doses of epinephrine on myocardial perfusion and resuscitation success during cardiopulmonary-resuscitation in a pig model. Am J Emerg Med 9 1 (1991) 27-31
90. Lindner K.H., Haak T., Keller A., Bothner U., and Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 75 2 (1996) 145-150
91. Lindner K.H., Prengel A.W., Brinkmann A., Strohmenger H.U., Lindner I.M., and Lurie K.G. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 124 12 (1996) 1061-1064
92. Lindner K.H., Dirks B., Strohmenger H.U., Prengel A.W., Lindner I.M., and Lurie K.G. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 349 9051 (1997) 535-537
93. Lipman J., Wilson W., Kobilski S., Scribante J., Lee C., Kraus P., et al. High-dose adrenaline in adult in-hospital asystolic cardiopulmonary-resuscitation - a double-blind randomized trial. Anaesth Intensive Care 21 2 (1993) 192-196
94. Livesay J.J., Follette D.M., Fey K.H., Nelson R.L., DeLand E.C., Barnard R.J., et al. Optimizing myocardial supply/demand balance with α-adrenergic drugs during cardiopulmonary resuscitation. J Thorac Cardiovasc Surg 76 2 (1978) 244-251
95. Martinez M.A., Fernandez N., Garcia-Villalon A.L., Monge L., and Dieguez G. Comparison of the in vivo coronary action of endothelin-1 and vasopressin role of nitric oxide and prostanoids. Vasc Pharmacol 40 5 (2003) 247-252
96. Marwick T.H., Case C., Siskind V., and Woodhouse S.P. Adverse effect of early high-dose adrenaline on outcome of ventricular fibrillation. Lancet 2 8602 (1988) 66-68
97. Mayer B., and Schunkert H. The higher, the better? Blood pressure after acute myocardial infarction. J Hypertens 25 2 (2007) 273-274
98. McGrath J.C. Evidence for more than one type of post-junctional α-adrenoceptor. Biochem Pharmacol 31 4 (1982) 467-484
99. Mehta, D., Ed. (2006). British National Formulary. London, The British Medical Association and The Royal Pharmaceutical Society of Great Britain.
100. Melo L.G., Gnecchi M., Pachori A.S., Kong D., Wang K., Liu X., et al. Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol 24 10 (2004) 1761
101. Michael J.R., Guerci A.D., Koehler R.C., Shi A.Y., Tsitlik J., Chandra N., et al. Mechanisms by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 69 4 (1984) 822-835
102. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 2 (2005) 179-190
103. Monteiro P., Duarte A.I., Moreno A., Goncalves L.M., and Providencia L.A. Carvedilol improves energy production during acute global myocardial ischaemia. Eur J Pharmacol 482 1-3 (2003) 245-253
104. Morris D.C., Dereczyk B.E., Grzybowski M., Martin G.B., Rivers E.P., Wortsman J., et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 4 9 (1997) 878-883
105. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74 5 (1986) 1124-1136
106. Nielsen H., Hasenkam J.M., Pilegaard H.K., Mortensen F.V., and Mulvany M.J. α-Adrenoceptors in human resistance arteries from colon, pericardial fat, and skeletal muscle. Am J Physiol Heart Circ Physiol 261 3 (1991) H762-H767
107. Niemann J.T., and Garner D. Post-resuscitation plasma catecholamines after prolonged arrest in a swine model. Resuscitation 65 1 (2005) 97-101
108. Nolan J.P., Hazinski M.F., Steen P.A., and Becker L.B. Controversial topics from the 2005 International Consensus Conference on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 67 2-3 (2005) 175-179
109. Olson D.W., Thakur R., Stueven H.A., Thompson B., Gruchow H., Hendley G.E., et al. Randomized study of epinephrine versus methoxamine in prehospital ventricular-fibrillation. Ann Emerg Med 18 3 (1989) 250-253
110. Paradis N.A., Martin G.B., Rivers E.P., Goetting M.G., Appleton T.J., Feingold M., et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA- J Am Med Assoc 263 8 (1990) 1106-1113
111. Paradis N.A., Martin G.B., Rosenberg J., Rivers E.P., Goetting M.G., Appleton T.J., et al. The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA 265 9 (1991) 1139-1144
112. Parikh V., and Singh M. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol Res 40 2 (1999) 129-137
113. Pearson J.W., and Redding J.S. Epinephrine in cardiac resuscitation. Am Heart J 66 2 (1963) 210-214
114. Pearson J.W., and Redding J.S. Management of cardiac arrest. The Lancet 283 7331 (1964) 492-493
115. Pearson J.W., and Redding J.S. Cardiac arrest and adrenaline. The Lancet 283 7339 (1964) 935
116. 2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 108 21 (2003) 2716-2721
117. Pentel P., and Benowitz N. Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies. Clin Pharmacokinet 9 4 (1984) 273-308
118. Piper H.M., Abdallah Y., and Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61 3 (2004) 365-371
119. Poullis D.M. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 101 16 (2000) E174-E175
120. Roberts D., Landolfo K., Dobson K., and Light R.B. The effects of methoxamine and epinephrine on survival and regional distribution of cardiac output in dogs with prolonged ventricular fibrillation. Chest 98 4 (1990) 999-1005
121. 2-Adrenoceptor-mediated contractions of the porcine isolated ear artery: evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism. Br J Pharmacol 124 6 (1998) 1107
122. Roffey P., Thangathurai D., Mikhail M., and Shoemaker W. Implication of epinephrine-induced hypokalemia during cardiac arrest. Resuscitation 58 2 (2003) 231
123. 2-adrenoceptors. J Surg Res 62 2 (1996) 192-196
124. Schafers R.F., Nurnberger J., Herrmann B., Wenzel R.R., Philipp T., and Michel M.C. Adrenoceptors mediating the cardiovascular and metabolic effects of α-methylnoradrenaline in humans. J Pharmacol Exp Ther 289 2 (1999) 918-925
125. Schoemig A., and Richard G. Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline. In: Heusch G., and Ross J. (Eds). Adrenergic mechanisms in myocardial ischemia (1991), Steinkopff Verlag, Darmstadt 9-30
126. Schwartz L.M., and Lagranha C.J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 290 3 (2006) H1011-H1018
127. Shah B.H., Lashari I., Rana S., Saeed O., Rasheed H., and Arshad Saeed S. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways. Pharmacol Res 42 5 (2000) 479-483
128. Sherman B.W., Munger M.A., Foulke G.E., Rutherford W.F., and Panacek E.A. High-dose versus standard-dose epinephrine treatment of cardiac arrest after failure of standard therapy. Pharmacotherapy 17 2 (1997) 242-247
129. Sternbach G. George W. Crile: the pneumatic rubber suit. J Emerg Med 1 5 (1984) 439-442
130. Stiell I.G., Hebert P.C., Weitzman B.N., Wells G.A., Raman S., Stark R.M., et al. High-dose epinephrine in adult cardiac-arrest. N Engl J Med 327 15 (1992) 1045-1050
131. Stiell I.G., Hebert P.C., Wells G.A., Vandemheen K.L., Tang A.S.L., Higginson L.A.J., et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 358 9276 (2001) 105-109
132. 2-adrenergic agonist for cardiac resuscitation. J Am Coll Cardiol 37 3 (2001) 951-956
133. Tang W., Weil M.H., Gazmuri R.J., Sun S., Duggal C., and Bisera J. Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation 84 5 (1991) 2101-2107
134. 2-type by B-HT 933. Eur J Pharmacol 63 2-3 (1980) 199-202
135. Tisi P.V., and Shearman C.P. Systemic consequences of reperfusion. In: Grace P.A., and Mathie R.T. (Eds). Ischaemia-reperfusion injury (1999), Blackwell Science Ltd., Oxford 20-30
136. Tovar O.H., and Jones J.L. Epinephrine facilitates cardiac fibrillation by shortening action potential refractoriness. J Mol Cell Cardiol 29 5 (1997) 1447-1455
137. 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69 2 (1981) 205-208
138. Voelckel W.G., Lurie K.G., Lindner K.H., Zielinski T., McKnite S., Krismer A.C., et al. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth Analg 91 3 (2000) 627-634
139. Warren E.T., Pass H.I., and Crawford Jr. F.A. External cardiopulmonary resuscitation augmented by the military antishock trousers. Am Surg 49 12 (1983) 651-654
140. Weber N.C., and Schlack W. The concept of anaesthetic-induced cardioprotection: mechanisms of action. Best Pract Res Clin Anaesthesiol 19 3 (2005) 429-443
141. Weisfeldt M.L., and Becker L.B. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. J Am Med Assoc 288 23 (2002) 3035-3038
142. Wenzel V., Lindner K.H., Krismer A.C., Miller E.A., Voelckel W.G., and Lingnau W. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 99 10 (1999) 1379-1384
143. Wenzel V., Krismer A.C., Arntz H.R., Sitter H., Stadlbauer K.H., Lindner K.H., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 2 (2004) 105-113
144. Weston C.F.M., Jones S.D., and Wilson R.J. Outcome of out-of-hospital cardiorespiratory arrest in South Glamorgan. Resuscitation 34 3 (1997) 227-233
145. Williamson K.L., and Broadley K.J. Do both adrenaline and noradrenaline stimulate cardiac α-adrenoceptors to induce positive inotropy of rat atria?. Br J Pharmacol 98 2 (1989) 597-611
146. Woodhouse S.P., Cox S., Boyd P., Case C., and Weber M. High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation 30 3 (1995) 243-249
147. Yap Y.G., Duong T., Bland J.M., Malik M., Torp-Pederson C., Kober L., et al. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials. J Hypertens 25 2 (2007) 307-313
148. Yassin M.M.I., Harkin D.W., D'Sa A.A.B.B., Halliday M.I., and Rowlands B.J. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg 26 1 (2002) 115-121
149. Yates J.C., and Dhalla N.S. Induction of necrosis and failure in the isolated perfused rat heart with oxidised isoproterenol. J Mol Cell Cardiol 7 (1975) 807-816
150. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 4 (2003) 1113-1151
151. Zhong J.-Q., and Dorian P. Epinephrine and vasopressin during cardiopulmonary resuscitation. Resuscitation 66 3 (2005) 263-269